Unibest

Pharmaceutical intermediates

Ertugliflozin Intermediates

2 pharmaceutical intermediates for Ertugliflozin. Indication: Type 2 diabetes mellitus.

提交项目All intermediates

About Ertugliflozin

Originator
Pfizer Inc
Indication
Type 2 diabetes mellitus
Approved Date
12/19/2017
DS/DP
07/13/2030

Available intermediates

2 intermediates currently listed for Ertugliflozin. Request specifications, documentation or a quotation for any item below.

Ertugliflozin intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
2-((benzyloxy)(4-ethoxyphenyl)methyl)-4-bromo-1-chlorobenzene1298086-15-3//
(2R, 3S.4S)-2, 3, 4-tris(benzyloxy)-4-((R)-4-((benzyloxy)meth yl)-2, 2-dimeth yl-1, 3- dioxolan-4-yl)-1-(4-methylDiDerazin-1-yl)butan-1-one1431329-07-5//

Other programs under E

Edoxaban tosylate monohydrateElacestrantElagolix SodiumEldecalcitolElinzanetantElobixibatEltrombopagEltrombopag Olamine

Building toward Ertugliflozin?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →